Free previewYou're reading the free part of this topic. The rest is included with Clinical.See what's included
Vernal Keratoconjunctivitis
Cornea
1. Clinical Analogy & Conceptual Overview
The Overenthusiastic Bouncer Analogy
Imagine an overzealous security bouncer (the immune system) stationed at the eye's front door (conjunctiva). In VKC, this bouncer - particularly his IgE-armed mast cells and Th2 lymphocytes - is so hyperactive that even a harmless summer breeze (seasonal allergen) triggers him to release a storm of inflammatory mediators. The repeated overreaction causes structural remodeling of the conjunctiva (papillae, fibrosis) and progressive corneal damage - the innocent bystander paying the price.
Definition
- Vernal keratoconjunctivitis is a chronic, bilateral, recurrent, external ocular inflammatory disease predominantly affecting the tarsal and/or limbal conjunctiva.
- Characterized by giant papillae, itching, and corneal involvement.
- Predominantly affects males, in the first two decades of life, and is often associated with atopic disease and allergic comorbidities.
- Has a geographical predilection.
- Self-limiting in most cases (resolves around puberty).
- Corneal complications can be vision-threatening.
2. Epidemiology & Risk Factors
Key Epidemiological Facts
- Vernal keratoconjunctivitis (VKC) is most prevalent in hot, dry climates - the Indian subcontinent, the Middle East, West Africa, and the Mediterranean basin.
- Environmental factors, including sunlight, heat, wind, and airborne allergens, can aggravate vernal keratoconjunctivitis (VKC) in susceptible individuals; their precise causal role in disease development remains incompletely understood.
| Parameter | Detail |
|---|---|
| Age of onset | • Usually starts before 10 years of age |
| Sex ratio | • Male:Female = 2–4:1 • Ratio becomes almost equal after 20 years of age |
| Laterality | • Bilateral • May be asymmetric |
| Seasonality | • Spring–summer (hence 'Vernal') • May become perennial after a few years |
| Atopy association | • Family history of allergic disorders reported in 49% |
| Natural history | • Generally resolves after puberty • Usually around 4–10 years after onset |
| Prevalence | • More common in Mediterranean areas, central and west Africa, the Middle East, Japan, the Indian subcontinent, and South America • Also occurs in Western Europe, Australia, and North America |
| Recurrence | • Seasonal exacerbations are common • Initially seasonal disease may become perennial after a few years • Some patients have year-round disease without remission |
| Parameter | Detail |
|---|---|
| Age of onset | • Usually starts before 10 years of age |
| Sex ratio | • Male:Female = 2–4:1 • Ratio becomes almost equal after 20 years of age |
| Laterality | • Bilateral • May be asymmetric |
| Seasonality | • Spring–summer (hence 'Vernal') • May become perennial after a few years |
| Atopy association | • Family history of allergic disorders reported in 49% |
| Natural history | • Generally resolves after puberty • Usually around 4–10 years after onset |
| Prevalence | • More common in Mediterranean areas, central and west Africa, the Middle East, Japan, the Indian subcontinent, and South America • Also occurs in Western Europe, Australia, and North America |
| Recurrence | • Seasonal exacerbations are common • Initially seasonal disease may become perennial after a few years • Some patients have year-round disease without remission |
Free preview ends here
Keep reading Vernal Keratoconjunctivitis
16 more sections are included with the Clinical plan.
- Epidemiology and Risk Factors - Viva / Exam Pearls
- Immunopathogenesis & Pathophysiology
- Classification & Forms
- Classification and Forms - Viva / Exam Pearls
- Clinical Features - Symptoms & Signs
- Hallmark Signs and Grading - Viva / Exam Pearls